Inventor · disambiguated record
Laura Carter
Also filed as: CARTER LAURA · CARTER LAURA L · CARTER LAURA LEE
8 granted patents·4 pending applications·1,655 citations·filing 2001–2022
90Inventor score
Top patents by PatentIndex Score
12 records- 0197US7521051B2Methods of upmodulating adaptive immune response using anti-PD-1 antibodiesMEDIMMUNE LTD·Filed 2003·Granted Apr 21, 2009·376 cites·15 claims
- 0296US8088905B2Nucleic acids encoding antibodies against PD-1COLLINS MARY·Filed 2009·Granted Jan 3, 2012·104 cites·6 claims
- 0396US7488802B2Antibodies against PD-1WYETH CORP·Filed 2003·Granted Feb 10, 2009·1.1k cites·23 claims
- 0486US7198789B2Methods and compositions for modulating interleukin-21 receptor activityGENETICS INST LLC·Filed 2002·Granted Apr 3, 2007·32 cites·66 claims
- 0584US7189400B2Methods of treatment with antagonists of MU-1GENETICS INST LLC·Filed 2001·Granted Mar 13, 2007·20 cites·38 claims
- 0675US2023201346A1Binding molecules specific for il-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0773US10022443B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2015·Granted Jul 17, 2018·1 cites·17 claims
- 0867US11529415B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·0 cites·14 claims
- 0967US10588969B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·0 cites·14 claims
- 1060US2008311117A1Antibodies against PD-1 and uses thereforCOLLINS MARY·Filed 2007·Application pending·0 cites
- 1142US2015044168A1Treatment of Multiple Sclerosis With Anti-CD19 AntibodyMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 1232US2017159089A1Method of producing glucose from a cellulosic biomass using enzymatic hydrolysisARBIOM INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laura Carter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →